About Us

Learn what makes us the best at what we do

What We Do

We can assist with screening animal or human tissues, working on quantitative biomarker target validation and distribution, Proof of Concept/Mechanism studies, Tissue Cross-Reactivity screening, Companion Diagnostic testing, Histology, Pathology analysis (Medical and Veterinary), Digital Pathology, Image Analysis and Human tissue sourcing.

HistologiX is also licensed by the Human Tissue Authority (HTA) to source and store human tissue and has ethical approval to undertake antibody screening in human tissues.

Why Choose Us?

Histologix as a GLP/GCP accredited laboratory, is compliant with all the relevant guidelines associated with undertaking regulatory preclinical safety assessments and assessments of patient samples from clinical trials.

We have two suites of dedicated laboratories situated within BioCity, Nottingham, UK that are equipped with state-of-the-art equipment and necessary platforms to support our services.

We can progress as a partner in your drug delivery program, from target identification, through biomarker development, in vivo studies to full clinical trial assessment.

We have an astounding track record and have and 80% customer retention rate.

To grow our company and develop our services, we continually invest in cutting edge equipment to ensure we can deliver results which are robust, consistent, reproducible and accurate to fully meet our client’s requirements.

We work in close collaboration with our clients to become an extension of their in-house teams. But don’t take our word for it. Read what our clients have to say

HistologiX assisted us with the analysis of tissue samples from our clinical study.  The sample analysis was challenging but HistologiX were very professional and able to meet a very tight deadline.  It was a pleasure to work with them.”

From a Swiss client

Who We Are

HistologiX was formed in 2005 as an independent GCP and GLP accredited contract research laboratory and has retained this status by inspection from the MHRA. We provide Histology, Immunohistochemistry and Digital Pathology services to the Pharmaceutical and Biotechnology industries. With our laboratories based in the UK, our customer base is global.

Our Directors, Laboratory Managers, Study Directors and Research Scientists have in excess of 120 years of experience within this niche area. We take great pride in helping our clients accelerate drug development and approval by providing world leading solutions. Our scientific expertise, innovative culture and integrity underpin our brand.

Histologix continues to work closely with a range of clients that include some of the top pharmaceutical companies worldwide as well as small and medium but highly innovative biotechnology companies.

Andrew Lawrence MSc

Andrew Lawrence MSc

Founder and company Director

Having begun his scientific career within the diagnostic environment of the Pathology Department of Leicester Royal Infirmary, Andrew subsequently joined Huntingdon Life Sciences as Head of Specialised Histological Techniques. There he introduced and developed a range of specialised histology technologies including IHC, particularly human tissue cross-reactivity testing. Prior to setting up HistologiX Ltd, Andrew worked at Source BioScience where he was involved with the development of cell signalling biomarkers. Andrew is currently managing the facility and has a wealth of knowledge of screening many different types of antibody and other therapeutic molecules.

Susan Smith BSc

Susan Smith BSc

Histology Lab Manager & Study Director

Susan is the Histology Lab Manager at HistologiX and is responsible for the management and coordination of the Histology studies.  She has expert knowledge of frozen sectioning, tissue processing/embedding, microtomy, routine and special staining, IHC, IF and ISH.

Having begun her scientific career within the Pharmaceutical environment of the Histology Department at Boots Pharmaceuticals, Susan subsequently joined Astra as a Histology Technician where she performed histology techniques, special staining and IHC techniques. This later became AstraZeneca. Susan had a brief career change and worked as a Microbiologist for a Manufacturing Company for several years before returning to the Pharmaceutical Industry. Throughout her career Susan has been Health and Safety Representative for the departments that she has worked in and has gained IOSH accreditation. At HistologiX, Susan prepares COSHH & Risk Assessments, ensuring compliance with Health and Safety regulations.

Elaine Foster BSc

Elaine Foster BSc

IHC Lab Manager & Study Director

Elaine is the IHC Manager at HistologiX and is responsible for the management and coordination of the IHC studies. Elaine began her scientific career in the Histopathology department of Queen’s Medical Centre sectioning breast and colon cancer tissues and performing IHC & radioactive-ISH assays. Elaine moved to a research group within the University of Leicester whose focus was IgA nephropathy. During that time she gained experience in a wide range of techniques, and was responsible for the management of expenditure for the grant accounts and Health and Safety. At Medical Solutions plc (Source BioScience), Elaine took a change of direction moving working as part of the drug discovery team where she helped set up GLP procedures within the laboratory. In 2006 she joined HistologiX, initially as a member of the histology and IHC teams and then progressing to IHC lab Manager. With her extensive practical experience of IHC techniques, she is well placed to support clients from project proposal to completion of study report.


Sunita Mistry MRes

Sunita Mistry MRes

Business Development Manager.

Sunita joined HistologiX in November 2015 as the Business Development Manager. With her sales and scientific background, she is well placed to devise project proposals through scientific discussion, and strengthen the relationship with clients.

Within the NHS, Sunita qualified as a Biomedical Scientist in Histology and worked in various histopathology laboratories. Following this, Sunita completed a Masters in Research and then gained experience in Molecular Pathology (Oncology) within Large Pharma. As a Research Scientist, she worked on IHC, FISH, method development, digital image analysis and study reporting within the preclinical and clinical drug development setting. Sunita worked in commercial and training roles for one of largest global providers of digital pathology, before joining HistologiX.